Citations (39)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (7)
Kimia Kardani, Seyed Mehdi Sadat, Mona Kardani & Azam Bolhassani. (2021) The next generation of HCV vaccines: a focus on novel adjuvant development. Expert Review of Vaccines 20:7, pages 839-855.
Read now
Read now
Kimia Kardani, Parya Basimi, Mehrshad Fekri & Azam Bolhassani. (2020) Antiviral therapy for the sexually transmitted viruses: recent updates on vaccine development. Expert Review of Clinical Pharmacology 13:9, pages 1001-1046.
Read now
Read now
Farzin Roohvand, Mehdi Shokri, Meghdad Abdollahpour-Alitappeh & Parastoo Ehsani. (2017) Biomedical applications of yeast- a patent view, part one: yeasts as workhorses for the production of therapeutics and vaccines. Expert Opinion on Therapeutic Patents 27:8, pages 929-951.
Read now
Read now
Sara Mohammadzadeh, Farzin Roohvand, Arash Memarnejadian, Anis Jafari, Soheila Ajdary, Ali-Hatef Salmanian & Parastoo Ehsani. (2016) Co-expression of hepatitis C virus polytope–HBsAg and p19-silencing suppressor protein in tobacco leaves. Pharmaceutical Biology 54:3, pages 465-473.
Read now
Read now
James I Dunlop, Anna M Owsianka, Vanessa M Cowton & Arvind H Patel. (2015) Current and future prophylactic vaccines for hepatitis C virus. Vaccine: Development and Therapy 5, pages 31-44.
Read now
Read now
Elodie Beaumont & Philippe Roingeard. (2013) Prospects for prophylactic hepatitis C vaccines based on virus-like particles. Human Vaccines & Immunotherapeutics 9:5, pages 1112-1118.
Read now
Read now
Bertrand Bellier & David Klatzmann. (2013) Virus-like particle-based vaccines against hepatitis C virus infection. Expert Review of Vaccines 12:2, pages 143-154.
Read now
Read now
Articles from other publishers (32)
Natalia Echeverría, Victoria Comas, Fabián Aldunate, Paula Perbolianachis, Pilar Moreno & Juan Cristina. (2021) In the era of rapid mRNA-based vaccines: Why is there no effective hepatitis C virus vaccine yet?. World Journal of Hepatology 13:10, pages 1234-1268.
Crossref
Crossref
Armina Alagheband Bahrami, Mojgan Bandehpour, Bahram Kazemi, Mahmood Bozorgmehr, Nariman Mosaffa & Rouzbeh Chegeni. (2020) Assessment of a poly-epitope candidate vaccine against Hepatitis B, C, and poliovirus in interaction with monocyte-derived dendritic cells: An ex-vivo study. Human Immunology 81:5, pages 218-227.
Crossref
Crossref
Karen Basen-Engquist, Powel Brown, Adriana M. Coletta, Michelle Savage, Karen Colbert Maresso & Ernest Hawk. 2020. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
337
374.e12
.
Elena Removna Chernykh, Ekaterina Alexandrovna Oleynik, Olga Yur’evna Leplina, Natalya Mihaylovna Starostina & Alexander Anatolievich Ostanin. (2019) Dendritic cells in the pathogenesis of viral hepatitis C. Russian Journal of Infection and Immunity 9:2, pages 239-252.
Crossref
Crossref
Muhammad Usman Ashraf, Kanzal Iman, Muhammad Farhan Khalid, Hafiz Muhammad Salman, Talha Shafi, Momal Rafi, Nida Javaid, Rashid Hussain, Fayyaz Ahmad, Syed Shahzad‐Ul‐Hussan, Shaper Mirza, Muhammad Shafiq, Samia Afzal, Sadia Hamera, Saima Anwar, Romena Qazi, Muhammad Idrees, Sohail A. Qureshi & Safee Ullah Chaudhary. (2018) Evolution of efficacious pangenotypic hepatitis C virus therapies. Medicinal Research Reviews 39:3, pages 1091-1136.
Crossref
Crossref
Fengqin Zhu, Yibo Wang, Zhen Xu, Haiyang Qu, Hairong Zhang, Lingling Niu, Honglu Xue, Dehuai Jing & Heng He. (2018) Novel adeno‑associated virus‑based genetic vaccines encoding hepatitis C virus E2 glycoprotein elicit humoral immune responses in mice. Molecular Medicine Reports.
Crossref
Crossref
Xuan Guo, Jin-Yi Zhong & Jun-Wen Li. (2018) Hepatitis C Virus Infection and Vaccine Development. Journal of Clinical and Experimental Hepatology 8:2, pages 195-204.
Crossref
Crossref
Elena Chernykh, Olga Leplina, Ekaterina Oleynik, Marina Tikhonova, Tamara Tyrinova, Natalia Starostina & Alexandr Ostanin. (2017) Immunotherapy with interferon-α-induced dendritic cells for chronic HCV infection (the results of pilot clinical trial). Immunologic Research 66:1, pages 31-43.
Crossref
Crossref
Farhad Motavalli Khiavi, Arash Arashkia, Majid Golkar, Maryam Nasimi, Farzin Roohvand & Kayhan Azadmanesh. (2018) A Dual-Type L2 11-88 Peptide from HPV Types 16/18 Formulated in Montanide ISA 720 Induced Strong and Balanced Th1/Th2 Immune Responses, Associated with High Titers of Broad Spectrum Cross-Reactive Antibodies in Vaccinated Mice. Journal of Immunology Research 2018, pages 1-15.
Crossref
Crossref
Annette von Delft, Timothy A. Donnison, José Lourenço, Claire Hutchings, Caitlin E. Mullarkey, Anthony Brown, Oliver G. Pybus, Paul Klenerman, Senthil Chinnakannan & Eleanor Barnes. (2018) The generation of a simian adenoviral vectored HCV vaccine encoding genetically conserved gene segments to target multiple HCV genotypes. Vaccine 36:2, pages 313-321.
Crossref
Crossref
Kouka Saadeldin Abdelwahab. (2016) Status of hepatitis C virus vaccination: Recent update. World Journal of Gastroenterology 22:2, pages 862.
Crossref
Crossref
Fengqin Zhu, Tian Chen, Yeqiong Zhang, Haixia Sun, Hong Cao, Jianxi Lu, Linshan Zhao & Gang Li. (2015) A Novel Adeno-Associated Virus–Based Genetic Vaccine Encoding the Hepatitis C Virus NS3/4 Protein Exhibits Immunogenic Properties in Mice Superior to Those of an NS3-Protein-Based Vaccine. PLOS ONE 10:11, pages e0142349.
Crossref
Crossref
Sara Mohammadzadeh, Farzin Roohvand, Soheila Ajdary, Parastoo Ehsani & Ali Hatef Salmanian. (2015) Heterologous Expression of Hepatitis C Virus Core Protein in Oil Seeds of Brassica napus L.. Jundishapur Journal of Microbiology 8:11.
Crossref
Crossref
Dapeng Li, Zhong Huang & Jin Zhong. (2015) Hepatitis C virus vaccine development: old challenges and new opportunities. National Science Review 2:3, pages 285-295.
Crossref
Crossref
Jason Gummow, Yanrui Li, Wenbo Yu, Tamsin Garrod, Danushka Wijesundara, Amelia J. Brennan, Ranajoy Mullick, Ilia Voskoboinik, Branka Grubor-Bauk & Eric J. Gowans. (2015) A Multiantigenic DNA Vaccine That Induces Broad Hepatitis C Virus-Specific T-Cell Responses in Mice. Journal of Virology 89:15, pages 7991-8002.
Crossref
Crossref
Michael G. Shehat, Mohammed Bahey-El-Din, Mervat A. Kassem, Faten A. Farghaly, Medhat H. Abdul-Rahman & Nourhan H. Fanaki. (2015) Recombinant expression of the alternate reading frame protein (ARFP) of hepatitis C virus genotype 4a (HCV-4a) and detection of ARFP and anti-ARFP antibodies in HCV-infected patients. Archives of Virology 160:8, pages 1939-1952.
Crossref
Crossref
Faezeh Ghasemi. (2015) Progress in the development of vaccines for hepatitis C virus infection. World Journal of Gastroenterology 21:42, pages 11984.
Crossref
Crossref
Leila Pishraft-Sabet, Anna D. Kosinska, Sima Rafati, Azam Bolhassani, Tahereh Taheri, Arash Memarnejadian, Seyed-Moayed Alavian, Michael Roggendorf & Katayoun Samimi-Rad. (2014) Enhancement of HCV polytope DNA vaccine efficacy by fusion to an N-terminal fragment of heat shock protein gp96. Archives of Virology 160:1, pages 141-152.
Crossref
Crossref
Leila Pishraft Sabet, Tahereh Taheri, Arash Memarnejadian, Talat Mokhtari Azad, Fatemeh Asgari, Ramin Rahimnia, Seyed Moayed Alavian, Sima Rafati & Katayoun Samimi Rad. (2014) Immunogenicity of Multi-Epitope DNA and Peptide Vaccine Candidates Based on Core, E2, NS3 and NS5B HCV Epitopes in BALB/c Mice. Hepatitis Monthly 14:10.
Crossref
Crossref
Aqsa Ikram, Sadia Anjum & Muhammad Tahir. (2014) InSilico Identification and Conservation Analysis of B-cell and T-Cell Epitopes of Hepatitis C Virus 3a Genotype Enveloped Glycoprotein 2From Pakistan: A Step Towards Heterologous Vaccine Design. Hepatitis Monthly 14:4.
Crossref
Crossref
Christine Hartoonian, Zargham Sepehrizadeh, Mojtaba Tabatabai Yazdi, Yong Suk Jang, Lida Langroudi, Parisa Amir Kalvanagh, Babak Negahdari, Ali Karami, Massoumeh Ebtekar & Kayhan Azadmanesh. (2014) Enhancement of Immune Responses by Co-delivery of CCL19/MIP-3beta Chemokine Plasmid With HCV Core DNA/Protein Immunization. Hepatitis Monthly 14:3.
Crossref
Crossref
Gillian Martinez-Donato, Yalena Amador-Cañizares, Liz Alvarez-Lajonchere, Ivis Guerra, Angel Pérez, Jean Dubuisson, Czeslaw Wychowsk, Alexis Musacchio, Daylen Aguilar & Santiago Dueñas-Carrera. (2014) Neutralizing antibodies and broad, functional T cell immune response following immunization with hepatitis C virus proteins-based vaccine formulation. Vaccine 32:15, pages 1720-1726.
Crossref
Crossref
Daria Jacob, Claude Ruffie, Myriam Dubois, Chantal Combredet, Rogerio Amino, Pauline Formaglio, Olivier Gorgette, Gérard Pehau-Arnaudet, Charline Guery, Odile Puijalon, Jean-Christophe Barale, Robert Ménard, Frédéric Tangy & Monica Sala. (2014) Whole Pichia pastoris Yeast Expressing Measles Virus Nucleoprotein as a Production and Delivery System to Multimerize Plasmodium Antigens. PLoS ONE 9:1, pages e86658.
Crossref
Crossref
Franco M Buonaguro & Luigi BuonaguroBertrand BellierDavid Klatzmann. 2014. Virus-like Particles in Vaccine Development. Virus-like Particles in Vaccine Development
36
49
.
Therese B. Bevers, Powel H. Brown, Karen Colbert Maresso & Ernest T. Hawk. 2014. Abeloff's Clinical Oncology. Abeloff's Clinical Oncology
322
359.e12
.
Liesl M. Hagan, Paul Root Wolpe & Raymond F. Schinazi. (2013) Treatment as prevention and cure towards global eradication of hepatitis C virus. Trends in Microbiology 21:12, pages 625-633.
Crossref
Crossref
Maryam Yazdanian, Arash Memarnejadian, Mehdi Mahdavi, Seyed Mehdi Sadat, Fatemeh Motevali, Rouhollah Vahabpour, Hossein Khanahmad, Seyed Davar Siadat, Mohammad Reza Aghasadeghi & Farzin Roohvand. (2013) Immunization of Mice by BCG Formulated HCV Core Protein Elicited Higher Th1-Oriented Responses Compared to Pluronic-F127 Copolymer. Hepatitis Monthly 13:10.
Crossref
Crossref
Derry K Mercer & Deborah A O’Neil. (2013) Peptides as the next generation of anti-infectives. Future Medicinal Chemistry 5:3, pages 315-337.
Crossref
Crossref
Liesl M. Hagan & Raymond F. Schinazi. (2013) Best strategies for global HCV eradication. Liver International 33, pages 68-79.
Crossref
Crossref
Alan R. Shaw & Mark B. Feinberg. 2013. Clinical Immunology. Clinical Immunology
1095
1121
.
Seyed Younes Hosseini, Farzaneh Sabahi, Seyed Mohammad Moazzeni, Mohammad Hossein Modarressi, Mehdi Saberi Firoozi & Mehrdad Ravanshad. (2012) Construction and Preparation of Three Recombinant Adenoviruses Expressing Truncated NS3 and Core Genes of Hepatitis C Virus for Vaccine Purposes. Hepatitis Monthly 12:9.
Crossref
Crossref
Seyed Younes Hosseini, Farzaneh Sabahi, Seyed Mohammad Moazzeni, Mohammad Hossein Modarressi, Mehdi Saberi Firoozi & Mehrdad Ravanshad. (1970) Construction and Preparation of Three Recombinant Adenoviruses Expressing Truncated NS3 and Core Genes of Hepatitis C Virus for Vaccine Purposes. Hepatitis Monthly 12:8.
Crossref
Crossref